Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults

por Kirstein, Judith, Douglas, William, Thakur, Manoj, Boaz, Mark, Papa, Thomas, Skipetrova, Anna, Plennevaux, Eric
Publicado 2018

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

por Vigne, Claire, Dupuy, Martin, Richetin, Aline, Guy, Bruno, Jackson, Nicholas, Bonaparte, Matthew, Hu, Branda, Saville, Melanie, Chansinghakul, Danaya, Noriega, Fernando, Plennevaux, Eric
Publicado 2017

Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults

por Roa, Camilo C, de Los Reyes, Mari Rose A, Plennevaux, Eric, Smolenov, Igor, Hu, Branda, Gao, Faith, Ilagan, Hannalyn, Ambrosino, Donna, Siber, George, Clemens, Ralf
Publicado 2023

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)

por L’Azou, Maïna, Assoukpa, Jade, Fanouillere, Karen, Plennevaux, Eric, Bonaparte, Matthew, Bouckenooghe, Alain, Frago, Carina, Noriega, Fernando, Zambrano, Betzana, Ochiai, R Leon, Guy, Bruno, Jackson, Nicholas
Publicado 2018

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials

por Plennevaux, Eric, Moureau, Annick, Arredondo-García, José L, Villar, Luis, Pitisuttithum, Punnee, Tran, Ngoc H, Bonaparte, Matthew, Chansinghakul, Danaya, Coronel, Diana L, L’Azou, Maïna, Ochiai, R Leon, Toh, Myew-Ling, Noriega, Fernando, Bouckenooghe, Alain
Publicado 2018